Kyowa Hakko Kirin Expands KW-0761 To Relapsed T/NK Cell Lymphoma
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin has expanded clinical trials for KW-0761 for patients with adult T-cell lymphoma to include patients with relapsed and progressive T/NK cell lymphoma
Kyowa Hakko Kirin has expanded clinical trials for KW-0761 for patients with adult T-cell lymphoma to include patients with relapsed and progressive T/NK cell lymphoma. The expansion will allow the antibody drug to treat more patients, the company said. (Click here for more - Japanese language) "Kyowa Kirin Expands Blood Cancer Drug To Relapsed Patients" - Nikkei Sangyo News (10/18/2010) |